ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 180 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $24,554 | -42.6% | 3,801 | -33.0% | 0.01% | -50.0% |
| Q1 2023 | $42,797 | -67.3% | 5,676 | -56.0% | 0.01% | -67.4% |
| Q4 2022 | $130,738 | +37.6% | 12,906 | +33.9% | 0.04% | -8.5% |
| Q3 2022 | $95,000 | +955.6% | 9,639 | +984.3% | 0.05% | +683.3% |
| Q2 2022 | $9,000 | +28.6% | 889 | +31.7% | 0.01% | +50.0% |
| Q1 2022 | $7,000 | -12.5% | 675 | +20.3% | 0.00% | 0.0% |
| Q4 2021 | $8,000 | -33.3% | 561 | -5.1% | 0.00% | -50.0% |
| Q3 2021 | $12,000 | -36.8% | 591 | -32.6% | 0.01% | -33.3% |
| Q2 2021 | $19,000 | +18.8% | 877 | +85.4% | 0.01% | -53.8% |
| Q1 2021 | $16,000 | – | 473 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |